Nestle Develops New Products for Weight-Loss Drug Users

Nestle is looking to turn the rapid growth of GLP-1 weight-loss drugs into a new business opportunity by developing products specifically for people taking medicines such as Ozempic and Wegovy. The company is using artificial intelligence and nutritional science to study the effects of rapid weight loss and identify products that could support users’ nutritional needs.

Nestle’s research is focusing on issues associated with rapid weight loss, including muscle loss, reduced nutritional intake, hydration and changes in skin, hair and nail health. The company has already added collagen protein to products under its Vital Proteins brand and launched Boost Advanced Nutrition Shake in the U.S., while its Milo PRO High Protein drink is available in parts of Asia and Australia.

AI is playing an increasing role in Nestle’s product development, with internal systems analysing scientific research, consumer trends and a database of around 120,000 recipes. However, some nutrition experts question whether specialised products provide significant benefits compared with conventional protein-rich foods such as eggs, dairy, meat, beans, nuts and pulses.

Pic courtesy: google/ images are subject to copyright